Co-Authors
This is a "connection" page, showing publications co-authored by ERIC JONASCH and CAMILO JIMENEZ.
Connection Strength
0.163
-
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metab. 2009 Feb; 94(2):386-91.
Score: 0.082
-
A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma. Cancer Invest. 2008 Jul; 26(6):642-6.
Score: 0.080